Gonadotropins & Cox-2 in Ovarian Cancer Prevention
促性腺激素
基本信息
- 批准号:8447386
- 负责人:
- 金额:$ 35.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-05-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAgeAgingApoptosisAspirinBasement membraneBenignBiologicalBiologyCancer EtiologyCancer ModelChemicalsContraceptive AgentsDevelopmentDevicesDoseEnzymesEpidemiologyEpithelial CellsEtiologyFundingGene DosageGeneticGenotypeGerm CellsGoalsGonadotropinsGrowthHormonesImplantIncidenceInfusion proceduresInvestigationKnock-outKnowledgeLeadLongevityMalignant NeoplasmsMalignant neoplasm of ovaryMediatingMenopauseModelingMorphologyMusMutant Strains MiceMutationOncogenicOral ContraceptivesOrgan Culture TechniquesOvarianOvarian FollicleOvaryPathway interactionsPeptide HydrolasesPhenotypePhysiologyPoint MutationPost-Menopausal Hormone Replacement TherapyPostmenopausePrevention strategyPreventiveProgesteroneProgestinsProtein Tyrosine KinaseProto-Oncogene Protein c-kitReagentReproductive HistoryRiskRisk FactorsRoleStudy modelsSurfaceSystemTestingTranslatingTubular AdenomaTumor BiologyVariantWhite Spotsabstractingadenomabasecancer riskdesignfollow-upinhibitor/antagonistmouse modelmutant mouse modelneoplasticnull mutationovarian cancer preventionovarian neoplasmpractical applicationprematurepreventreproductiveresearch studytumortumorigenesis
项目摘要
Project Summary/Abstract
Epidemiological observations have established ovarian cancer risk factors, such as high cancer
incidence in peri- postmenopausal ages and preventive activity of oral contraceptives. However, the
mechanisms for these well-established ideas remain obscure, and experimental systems are highly desirable
to gain biological and mechanistic understanding of the epidemiological findings.
Menopausal ovaries undergo morphological changes, known as "ovarian aging" which are implicated in
the high incidence of ovarian cancer occurring during the peri-menopausal and immediate post-menopausal
periods. We explore a germ cell-deficient Wv (white spotting variant) mutant mouse line to model the impact of
menopausal physiology on the increased risk of ovarian cancer, and the model may also allow us to test
preventive agents. The Wv mice harbor a point mutation in c-Kit that reduces the tyrosine kinase activity to
about 1-5% (not a null mutation). The mutation results in a premature loss of ovarian germ cells and follicles,
but other biological phenotypes are very mild and the mice have a near normal life span. The germ cell-
deficient Wv mice recapitulate some of these post-menopausal alterations in ovarian morphology and develop
tubular adenomas. Furthermore, addition of oncogenic mutation such as loss of p27kip1 or loss of p53
converts the ovarian adenomas into neoplastic tumors. In preliminary experiments, suppression of Cox-1 was
found to delay ovarian follicle depletion in addition to suppressing tumor development. Among several
proteolytic enzymes investigated, we found that uPA was elevated in Wv ovaries, and we speculate that uPA
may be the underlying cause of Wv ovarian tumor phenotype.
The goal of the proposal is to use the Wv mouse models with additional oncogenic mutation to study
the mechanisms responsible for the menopausal increase in ovarian cancer risk and to test several potential
preventive approaches. First, we will further study the roles of Cox-1 in ovarian germ cell and follicle
maturation and survival, and ovarian tumor development (Aim 1). We also will investigate the importance of
uPA in ovarian tumor formation using the Wv mouse models, and the ability of uPA inhibitors to reduce ovarian
tumorigenesis (Aim 2). Lastly, we will use progestin to suppress gonadotropins in Wv mice to verify the
"follicle depletion hypothesis". The experiments will reveal whether follicle depletion or increased
gonadotropins is the principal cause of ovarian tumorigenesis in Wv mice (Aim 3).
These studies will address a fundamental mechanism of ovarian cancer etiology related to reproductive
factors and the roles and mechanisms of Cox-1, Cox-2, uPA, and progestins (oral contraceptives), which are
potential preventive targets/agents for ovarian cancer. Successful completion of the experiments will further
our understanding of the underlying mechanism for reproductive factors on ovarian cancer risk and provide
rationale for possible preventive approaches for ovarian cancer.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XiangXi Mike Xu其他文献
XiangXi Mike Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XiangXi Mike Xu', 18)}}的其他基金
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
10524246 - 财政年份:2018
- 资助金额:
$ 35.35万 - 项目类别:
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
10060282 - 财政年份:2018
- 资助金额:
$ 35.35万 - 项目类别:
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
9918266 - 财政年份:2018
- 资助金额:
$ 35.35万 - 项目类别:
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
10391479 - 财政年份:2018
- 资助金额:
$ 35.35万 - 项目类别:
Mechanism of Cox-2 Inhibition in Ovarian Cancer Prevention
抑制 Cox-2 预防卵巢癌的机制
- 批准号:
6958678 - 财政年份:2004
- 资助金额:
$ 35.35万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 35.35万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 35.35万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 35.35万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 35.35万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 35.35万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 35.35万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 35.35万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 35.35万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 35.35万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 35.35万 - 项目类别:
Research Grant














{{item.name}}会员




